predict valu tumor estrogen progesteron receptor level postmenopaus women advanc breast cancer toremifen predict valu estrogen receptor ER concentr group postmenopaus patient estrogen-receptor-posit ER fmol/mg protein breast cancer patient tumor progesteron receptor pgr determin patient toremifen novel antiestrogen mg median ER respond fmol/mg protein nonrespond fmol/mg protein median pgr level fmol/mg protein respons rate patient ER fmol/mg protein group ER fmol/mg protein signific NS respons rate patient pgr fmol/mg protein patient fmol/mg protein durat respons patient ER fmol/mg protein ER level pgr durat respons cox multipl regress analysi ER independ prognost factor respons durat ER concentr tumor tissu durat respons respons rate patient advanc breast cancer statu respons rate durat respons 